07.03.12
Pharming Group NV has signed an agreement to sell the assets of its U.S. operations to Sexing Technologies, a private company based in Navasota, TX. The sale includes the farm buildings and surrounding land in Wisconsin. Sexing Technologies specializes in the genetic improvement and reproductive services and global export of livestock, primarily through the production and commercialization of sexed sorted semen and embryos.
Pharming recently announced the closure of its U.S.-based cattle platform research operations to focus on its transgenic rabbit platform. The decision reflects the declining importance of transgenic cattle research, and legacy proteins such as fibrinogen, lactoferrin and collagen.
Pharming recently announced the closure of its U.S.-based cattle platform research operations to focus on its transgenic rabbit platform. The decision reflects the declining importance of transgenic cattle research, and legacy proteins such as fibrinogen, lactoferrin and collagen.